[DOI] [PMC free article] [PubMed] [Google Scholar] 45.Wallner M., Kolesnik E., Ablasser K., Khafaga M., Wakula P., Ljubojevic S., Thon-Gutschi E.M., Sourij H., Kapl M., Edmunds N.J., et al
Cancer Lett (2004) 208:15561
A Selective and Potent CXCR3 Antagonist SCH 546738 Attenuates the Development of Autoimmune Diseases and Delays Graft Rejection
This enables cell motility and tissue remodeling, key processes for regeneration and repair in muscle, tendon, and epithelial tissues 2
Healthcare professionals must consider whether weight loss will meaningfully improve health outcomes and quality of life in older patients, taking into account their overall clinical picture and life expectancy
Prioritizing Lean Protein As GLP-1 medications gain popularity, an increasing number of studies are emerging about their effects, and one of those side effects noted in several studies is muscle mass loss